Annual report pursuant to Section 13 and 15(d)

NOTES PAYABLE (Details Narrative)

v3.23.1
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Aug. 15, 2022
Feb. 09, 2021
Jun. 15, 2020
Dec. 31, 2022
Sep. 30, 2022
Aug. 31, 2022
Jul. 31, 2022
Jun. 30, 2022
Oct. 31, 2018
Dec. 31, 2022
Dec. 31, 2021
Sep. 16, 2022
Dec. 31, 2020
Debt Instrument [Line Items]                          
Weighted-average stated interest rate       8.00%           8.00% 6.00%    
Weighted-average effective interest rate       20.00%           20.00% 15.00%    
Prepayments of convertible debentures                   $ 350,000 $ 7,200,000    
Interest rate                 1.00%        
Loss on debt extinguishment                   501,000 365,000    
Debt instrument, maturity date                 Sep. 30, 2028        
Common stock       $ 50,000           $ 50,000 $ 49,000    
Common stock       49,583,501           49,583,501 49,311,864    
Issuance cost             $ 32,000            
Fair value of warrants             84,000            
Debt Instrument Principle Payments           $ 1,600,000              
Proceeds from convertible notes payable issued                     $ 14,490,000    
Purchase and Sales of Future Receipts [Member]                          
Debt Instrument [Line Items]                          
Installment payment       $ 103,500                  
Hope International Hospice, Inc. [Member]                          
Debt Instrument [Line Items]                          
Interest rate 10.00%                        
Principal amount $ 50,000                        
Prepayment amount $ 1,924,819                        
Seah Lim [Member]                          
Debt Instrument [Line Items]                          
Interest rate           6.00%              
Debt instrument, maturity date           Sep. 30, 2025              
Common stock           240,000              
Fair values of the embedded derivatives       62,000           $ 62,000   $ 68,000  
Principal amount           $ 1,200,000              
Receivables Purchased Amount [Member]                          
Debt Instrument [Line Items]                          
Loss on debt extinguishment       (79,000)                  
Receivables Purchased Amount [Member] | Emmaus Medical [Member]                          
Debt Instrument [Line Items]                          
Sale of accounts receivable         $ 694,960   816,000            
Proceeds from sale of notes receivable         500,000   516,000            
Weekly amount to be received under agreement by third party         $ 25,969   $ 34,000            
Purchased Amount [Member] | Purchase and Sales of Future Receipts [Member]                          
Debt Instrument [Line Items]                          
Sale of accounts receivable       3,105,000                  
Proceeds from sale of notes receivable       2,300,000                  
Revolving Line of Credit Facility [Member] | Prime Rate                          
Debt Instrument [Line Items]                          
Debt instrument variable annual rate                   3.00%      
Revolving Line of Credit Facility [Member] | Dr. Yutaka Niihara [Member]                          
Debt Instrument [Line Items]                          
Line of credit maximum borrowing capacity       1,000,000           $ 1,000,000      
Line of credit outstanding balance       $ 400,000           $ 400,000 $ 400,000    
Line of credit expiration date                   Nov. 22, 2022      
Convertible Promissory Note [Member] | Securities Purchase Agreement [Member]                          
Debt Instrument [Line Items]                          
Interest rate   2.00% 12.00%                   11.00%
Loss on debt extinguishment     $ 1,400,000                    
Proceeds from convertible notes payable issued   $ 14,500,000                      
Conversion price   $ 1.48   $ 0.37           $ 0.37      
Debt instrument, frequency of periodic payment                   The convertible promissory notes bear interest at the rate of 2% per year, payable semi-annually on the last business day of August and January of each year and will mature on the 3rd anniversary of the original issue date, unless earlier converted or prepaid.      
Convertible Promissory Note [Member] | Maximum [Member] | Securities Purchase Agreement [Member]                          
Debt Instrument [Line Items]                          
Principal amount   $ 17,000,000                      
Business Loan And Security Agreement [Member]                          
Debt Instrument [Line Items]                          
Loss on debt extinguishment           $ 422,000              
Principal amount               $ 1,800,000          
Net proceeds               1,666,000          
Installment payment               $ 738,000          
Prepayment Period               90 days          
Prepayment amount               $ 2,250,000          
Business Loan And Security Agreement [Member] | First Eight Weeks [Member]                          
Debt Instrument [Line Items]                          
Installment payment               31,725          
Business Loan And Security Agreement [Member] | Remaining Thirty Two Weeks [Member]                          
Debt Instrument [Line Items]                          
Installment payment               $ 71,381          
Promissory Notes [Member]                          
Debt Instrument [Line Items]                          
Interest rate           10.00% 12.00%            
Debt instrument, maturity date           Aug. 16, 2027 Jul. 31, 2027            
Promissory Notes [Member] | Unaffiliated Third Parties [Member]                          
Debt Instrument [Line Items]                          
Principal amount           $ 1,668,751 $ 402,000            
Promissory Notes [Member] | Personal Funds [Member]                          
Debt Instrument [Line Items]                          
Principal amount           250,000              
Promissory Notes [Member] | Dr Niihara And His Wife [Member]                          
Debt Instrument [Line Items]                          
Principal amount           $ 1,576,574 $ 370,000